Поисковый запрос: (<.>S=ТЕРОДИЛИН<.>) |
Общее количество найденных документов : 23
Показаны документы с 1 по 20
|
|
1.
| ('+-')-Terodiline: an M[1]-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion // Eur. J. Pharmacol., 1991. Vol. 201, N 2-3.-С.135-142
|
2.
| Abrams Terodiline in clinical practice // Urology, 1990. Vol. 36, N 4 Suppl..-С.50-57
|
3.
| Action potenials, contraction, and membrane currents in guinea pig ventricular preparations treated with the antispasmodic agent terodiline // J. Pharmacol. and Exp. Ther., 1999. Vol. 290, N 3.-С.1417-1426
|
4.
| Biotransformation of terodiline IV: Identification of unconjugated and conjugated metabolites in dog and human urine // Acta pharm. suec., 1988. Vol. 25, N 6.-С.281-292
|
5.
| Calcium antagonist effects on the rat bladder of Rec 15/2053, A new antispasmodic flavone-derivative // Neurourol. and urodyn, 1989. Vol. 8, N 4.-С.380-381
|
6.
| Comparison of the effects of NS-21 and terodiline on the QTc interval in dogs // Gen. Pharmacol., 1998. Vol. 30, N 1.-С.137-142
|
7.
| Comparison of the in vitro skin penetration of propiverine with that of terodiline // Biol. and Pharm. Bull., 1995. Vol. 18, N 7.-С.968-975
|
8.
| Effects of the anticholinergic drug prifinium bromide on urinary bladder contractions in rat in vivo and in guinea-pig in vitro // Arzneim.-Forsch, 1991. Vol. 41, N 4.-С.417-420
|
9.
| Ford G.A. CYP2D6 and CYP2C19 genotypes of patients with terodiline cardiotoxicity identified through the yellow card system // Brit. J. Clin. Pharmacol., 2000. Vol. 50, N 1.-С.77-80
|
10.
| Hallen B. Pharmacokinetics of terodiline and a major metabolite in dogs with a correlation to a pharmacodynamic effect // Pharmacol. and Toxicol., 1990. Vol. 66, N 5.-С.373-381
|
11.
| Langtry Heather D. Terodiline. A review of its pharmacological properties, and therapeutic use in the treatment of urinary incontinence // Drugs, 1990. Vol. 40, N 5.-С.748-761
|
12.
| Pharmacokinetic/pharmacodynamic assessment of the effects of E4031, cisapride, terfenadine and terodiline on monophasic action potential duration in dog // Xenobiotica, 2001. Vol. 31, N 8-9.-С.633-650
|
13.
| Spare Pharmacodynamics and pharmacokinetics of terodiline // Urology, 1990. Vol. 36, N 4 Suppl..-С.44-49
|
14.
| Stohrer M. Terodilin. Urologikum zur Behandlung von Blasenendeerungsstorungen // Arzneimitteltherapie, 1991. Vol. 9, N 4.-С.100-101
|
15.
| Tachycardia and terodiline // Lancet, 1991, N 8673.-С.344-345
|
16.
| Tel H. Terodiline (Mictrol) // Pharm. weekbl., 1990. Vol. 125, N 36.-С.936-939
|
17.
| Terodiline in the treatment of nocturnal enuresis in children // Int. Urol. and Nephrol., 1992. Vol. 24, N 5.-С.509-513
|
18.
| Torsades de pointes ventricular tachycardia and terodiline // Lancet., 1991, N 8763.-С.344-345
|
19.
| Влияния ('+-')-4'-этил-2-метил-3-(1-пирролидинил)пропиофенонгидрохлорида (HY-770) на функцию мочевого пузыря // Нихон якуригаку дзасси, 1988. Vol. 92, N 5.-С.311-324
|
20.
| Клиническое изучение теродилина гидрохлорида и кленбутерола гидрохлорида при частых мочеиспусканиях и при недержании мочи // Хинекика кие, 1991. Vol. 37, N 11.-С.1575-1580
|
&uf('+1W2226#',v2226), ?>
|
|